Articles & Video
Pharma/Biotech GTN Summit Benchmarking Report 2021
Explore the data from the Pharma/Biotech GTN Summit Benchmarking Report
Escalating GTN reductions puts pressure on sales
We explore how pharmaceutical manufacturers' sales funnels are being clogged by escalating gross-to-net (GTN) reductions.
Life Sciences Survey: COVID-19 Impacts One Year On
Take part in our industry survey on the impacts of COVID-19 on the life sciences one year on to get exclusive early access to the final report.
Executive Summary: Key Sessions from Life Sciences Accounting & Reporting Congress
Read the executive summary of some key sessions from the recent Life Sciences Accounting & Reporting Congress.
Diversity, Equity and Inclusion Beyond the Four Walls of an Organization
How have life sciences diversity efforts expanded beyond an organization’s four walls to encompass the entire ecosystem and to include social justice?
REPORT: Diversity, Equity and Inclusion in the Life Sciences 2021
Explore the Diversity, Equity and Inclusion in the Life Sciences 2021 report based on an exclusive study of 483 industry professionals.
SURVEY: Diversity, Equity and Inclusion in the Life Sciences 2021
Complete our survey on Diversity, Equity and Inclusion in the Life Sciences 2021 to get exclusive early access to the final report.
Blog Post: Impact of Medicare Part D Donut Hole on GTN
View this blog post for an inside look at the impact of Medicare Part D Donut Hole on GTN.
SURVEY: Partnering and Deal-Making in Biopharma through the Pandemic
We are conducting a huge study to gauge perspectives around biopharma deal-making during COVID-19 and the commercial ramifications of the pandemic. Take part here.
Containing Coronavirus Through Innovation and Investment: An Xconomy Special Report
This report contains ideas, innovation, and experience from some of the major players at the forefront of efforts in combatting COVID-19. The exclusive articles were captured from the BIO-Europe Spring® event and are accompanied by some of the most pertinent stories from B2B publications Xconomy and Bioprocess Insider.